Impact of closed loop stimulation on prognostic cardiopulmonary variables in patients with chronic heart failure and severe chronotropic incompetence: a pilot, randomized, crossover study.
Cardiac resynchronization therapy
Cardiopulmonary exercise testing
Closed loop stimulation
Rate-adaptive pacing
Severe chronotropic incompetence
Ventilatory efficiency slope
Journal
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649
Informations de publication
Date de publication:
08 11 2021
08 11 2021
Historique:
received:
28
10
2020
accepted:
30
04
2021
pubmed:
14
5
2021
medline:
1
4
2022
entrez:
13
5
2021
Statut:
ppublish
Résumé
Clinical effects of rate-adaptive pacing in heart failure patients with chronotropic incompetence (CI) undergoing cardiac resynchronization therapy (CRT) remain unclear. Closed loop stimulation (CLS) is a new rate-adaptive sensor in CRT devices. We evaluated the effectiveness of CLS in CRT patients with severe CI, focusing primarily on key prognostic variables assessed by cardiopulmonary exercise (CPX) testing. In the randomized, crossover, multicentre BIO|CREATE study, 20 CRT patients with severe CI and NYHA Class II/III (60%/40%) were randomized 1:1 to the sequence DDD-40 mode to DDD-CLS mode, or the sequence DDD-CLS mode to DDD-40 mode (1 month in each mode). Patients underwent symptom-limited treadmill-based CPX test in each mode. An improvement (decrease) of the ventilatory efficiency (VE) slope of ≥5% during CLS was regarded as positive response to CLS. Seventeen patients with full data sets had a mean intra-individual VE slope change of -1.8 ± 3.0 (-4.1%) with CLS (P = 0.23). Eight patients (47%) were CLS responders, with a -6.1 ± 2.7 (-16.4%) slope change (P = 0.029). Compared to non-responders, CLS responders had a higher left ventricular (LV) ejection fraction (46 ± 3 vs. 36 ± 9%; P = 0.0070), smaller end-diastolic LV volume (121 ± 34 vs. 181 ± 41 mL; P = 0.0085), smaller end-systolic LV volume (65 ± 23 vs. 114 ± 39 mL; P = 0.0076), and were predominantly in NYHA Class II (P = 0.0498). The data of the present pilot study are compatible with the notion that CLS activation may improve VE slope in CRT patients with severe CI and less advanced heart failure. Further research is needed to determine the long-term clinical outcomes of CLS.
Identifiants
pubmed: 33982093
pii: 6274946
doi: 10.1093/europace/euab110
pmc: PMC8576282
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
1777-1786Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.
Références
J Cardiovasc Electrophysiol. 2009 Jul;20(7):773-80
pubmed: 19207785
Open Cardiovasc Med J. 2010 May 26;4:127-34
pubmed: 20657715
Circulation. 2011 Mar 8;123(9):1010-20
pubmed: 21382903
Herzschrittmacherther Elektrophysiol. 2000 Dec;11(4):244-53
pubmed: 27515355
Circ Heart Fail. 2018 Aug;11(8):e004969
pubmed: 30354566
Pacing Clin Electrophysiol. 2004 Jan;27(1):24-32
pubmed: 14720151
Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):197-202
pubmed: 18391648
JACC Heart Fail. 2018 Feb;6(2):105-113
pubmed: 29226818
J Am Coll Cardiol. 2016 Apr 26;67(16):1885-96
pubmed: 27102504
J Am Coll Cardiol. 2005 Dec 20;46(12):2292-7
pubmed: 16360061
Eur J Heart Fail. 2014 Feb;16(2):201-9
pubmed: 24464973
Circulation. 2000 Jun 20;101(24):2803-9
pubmed: 10859285
J Cardiovasc Electrophysiol. 2012 Dec;23(12):1317-25
pubmed: 22830441
Europace. 2011 Oct;13(10):1459-63
pubmed: 21551475
Eur Heart J. 2013 Aug;34(29):2271-80
pubmed: 23315907
Europace. 2008 Mar;10(3):327-33
pubmed: 18272507
Eur J Heart Fail. 2008 Jan;10(1):96-101
pubmed: 18096432
Circ Heart Fail. 2010 May;3(3):405-11
pubmed: 20200329
N Engl J Med. 2005 Apr 14;352(15):1539-49
pubmed: 15753115